Physician profile
Cody Ricker
NPI 1730842170
$5,190.05
in general payments reported to CMS, 2019-2025
12 companies · $1,402 in 2025
The $1,402 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $502 · 2023: $807 · 2024: $2,479 · 2025: $1,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,716 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,425 · Travel and Lodging: $546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,716.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,425.00 |
| Travel and Lodging | $546.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,139.71 | 2022-2025 | Affera Mapping System |
| Boston Scientific Corporation | $1,270.60 | 2022-2025 | Emblem Mri S-Icd, General - Therapies, Watchman Access System |
| Philips North America LLC | $337.73 | 2023-2025 | (9520) Igt Devices Undivided, Lm Undivided |
| Atricure, INC. | $144.66 | 2023 | |
| Pfizer INC. | $104.60 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $36.55 | 2023-2024 | |
| Novo Nordisk INC | $35.19 | 2023 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $33.20 | 2022-2023 | Brilinta |
| Octapharma USA, INC. | $30.83 | 2025 | Fibryga |
| Angiodynamics, INC. | $21.75 | 2022 | |
| Irhythm Technologies, INC. | $20.84 | 2023 | Zio Xt Patch |
| Sanofi-Aventis U.S. LLC | $14.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Ricker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.